HDK may undergo heart surgery again

DHNS
September 19, 2017

Bengaluru, Sept 19: JD(S) leader H D Kumaraswamy has said that he will be out of action for the next fortnight owing to health complications.

Kumaraswamy, who said that he will be undergoing a valve replacement surgery on September 23, appealed to his supporters and party workers not to get anxious, as it was a routine procedure.

The JD(S) leader who had undergone heart surgery in December 2007, was scheduled for a valve replacement in the next two years.

‘Toll on health’

“However, for the last seven to eight months, I have been coughing incessantly, and this has taken a toll on my heart. The problem aggravated when I was travelling to Israel recently. I couldn’t walk steadily in the Mumbai airport, nor could I climb the stairs in Israel. I consulted some doctors there and they said I needed to undergo surgery immediately, but I put it off,” Kumaraswamy said.

Once in Bengaluru, Kumaraswamy underwent a series of tests and investigations. He is scheduled to be admitted to Jayadeva Institute of Cardiovascular Sciences and Research hospital in the next couple of days.

When contacted, noted cardiologist and director of Jayadeva, Dr C N Manjunath, said that a team of four to five experts including pulmonologists and cardiologists will first screen Kumaraswamy to determine whether the problem is respiratory or cardiac or interconnected.

“If the degree of the valve problem is significant, then we will go for a replacement surgery,” he added.

Comments

Danish
 - 
Tuesday, 19 Sep 2017

We will pray for you HDK.

Ganesh
 - 
Tuesday, 19 Sep 2017

If you are ready to quit from politics then people may pray for you...

Truth
 - 
Tuesday, 19 Sep 2017

Glad to hear that he has heart

Kumar
 - 
Tuesday, 19 Sep 2017

Everything will be alright (same like you peple telling to voters)

Rakesh
 - 
Tuesday, 19 Sep 2017

These are all your deeds

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
April 19,2020

Mangaluru, Apr 19: The covid-19 being spread by the novel coronavirus has claimed a life in the coastal district of Dakshina Kannada.  

The victim, a 50-year-old woman from Bantwal taluk, breathed her last at Wenlock Hospital today morning. 

She was rushed to a private hospital yesterday after she developed breathing problems. Then she was shifted to Wenlock Hospital's block for suspected coronavirus patients, and placed in the intensive care unit (ICU).

Her throat swab was collected the same day and sent for testing for coronavirus. However, today morning her condition worsened and she passed away.

The report was received on later on Sunday afternoon, which confirmed that she had contracted coronavirus.

The woman's family members including her husband, son and mother-in-law have been placed under quarantine. It is learnt that her mother-in-law's condition is serious and she has been admitted to the ICU.

The throat swabs of all the three family members have been sent for coronavirus test. According to sources, the woman's son had come from Dubai recently.

Meanwhile, a 30-year-old woman from Uppinangady, who is undergoing treatment in a hospital, today tested positive for the covid-19.

With the confirmation of two new cases, the total number of reported covid-19 cases in Dakshina Kannada reached 15. Out of which only two case are currently active and 12 have been discharged. Another one passed away.

Comments

Mohith R
 - 
Monday, 20 Apr 2020

I am her son and I returned from Dubai on FEBRUARY 13, not March 16. What fake source are you referring to?

 

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Pune/Bengaluru, Mar 25: e-Zest Solutions and Neurosynaptic Communications today announced the ReMeDi SCAN-CORONA platform, an innovative technology solution to help control the Novel COVID-19 pandemic.
As countries worldwide grapple to contain the spread and flatten the curve while treating the ones infected, the need of the hour is to deploy widespread screening and testing procedures to identify and isolate those showing symptoms.
The ReMeDi® SCAN-CORONA platform has a three-pronged approach to controlling the pandemic that makes the task of screening, testing, tracking and reporting extremely easy and manageable at a large scale.
"Mass screening and testing is the need of the hour. With the scarcity of healthcare professionals, there is a need of technology enabled platforms to do this at a large scale with minimal to no human intervention. The ReMeDi SCAN-CORONA brings together remote healthcare expertise and the power of emerging technology such as AI & ML, and promises to reduce the load on the healthcare system, so that timely care reaches the right set of people as fast as possible," said Shree Shingane - Founder and Managing Director, e-Zest Solutions GmbH.
The solution features a Corona-Screen Kit - a portable, lightweight kit that includes basic screening tools that seamlessly connect and feed data into a Patient Health Record (PHR) system without any manual intervention.
It also features a geo-tagging powered Screening app that, by importing and analyzing data from the screening tools as well as travel and medical history. The input from a third-party COVID-19 rapid testing kit further enhances the accuracy of the outcome.
"ReMeDi SCAN-CORONA helps front-line health workers to quickly assess the essential risk factors for a person digitally. It has the unique ability to track the progression of symptoms with time. The tele-consultation facility allows individuals to obtain counselling as well as consult doctors independent of location, to access timely information and guidance. We are proud to present this solution in collaboration with e-Zest," said Sameer Sawarkar CEO - Neurosynaptic.
The beauty of this solution is that while it can bring a big relief for COVID-19 screening efforts, it is equally advantageous to heavily burdened Healthcare Providers in remotely treating the non-corona health requirements as well.
The team acknowledges the valuable contribution in terms of clinical inputs for application development, from Dr Nandakumar, a renowned public health expert.
"e-Zest vision is to leverage Healthcare technologies to impact human life positively. We are happy to be part of this collaboration & look forward to it's contribution to combat the pandemic challenge globally," said Devendra Deshmukh, e-Zest CEO.
This story is provided by BusinessWire India. ANI will not be responsible in any way for the content of this article.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 4,2020

Mangaluru, Apr 4: The chemistry department of National Institute of Technology-Karnataka (NIT-K) here has started producing hand sanitizers in view of its shortage in the market after the coronavirus outbreak.

The social initiative led by Arun Isloor, professor and head of the department, was launched by NIT-K director K Uma Maheshwar Rao.

The raw materials needed for this product were provided by the institute.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.